Skip to main content
Clinical Trials/NCT02568865
NCT02568865
Completed
N/A

Non-Invasive Physiologic Sensors to Assess Depression

Massachusetts General Hospital1 site in 1 country50 target enrollmentJanuary 15, 2016

Overview

Phase
N/A
Intervention
Not specified
Conditions
Depression
Sponsor
Massachusetts General Hospital
Enrollment
50
Locations
1
Primary Endpoint
Physiologic Biorhythms (Skin conductance)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This project aims to use sensors to monitor physiological signals, sleep patterns, vocal characteristics, activity, location and phone usage in study patients with depression who are receiving standard treatment (compared with healthy controls).

Registry
clinicaltrials.gov
Start Date
January 15, 2016
End Date
January 3, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

David Mischoulon, MD, PhD

Director, Depression Clinical and Research Program

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • Patients with Depression (n=40):
  • Adults (ages 18-75),
  • Able to read, understand, and provide written informed consent in English,
  • Meet criteria for a primary psychiatric diagnosis of major depressive disorder for ≥ 4 weeks, according to the M.I.N.I (Mini International Neuropsychiatric Interview),
  • Hamilton Depression Rating Scale (HDRS) total score ≥ 18,
  • Engaged in or willing to be referred for clinical care for depression treatment as usual (antidepressants and/or psychotherapy),
  • Must have measurable skin conductance/electrodermal activity (as assessed at the screening visit),
  • Must own a working Android smartphone (Android 2.3+) and use it regularly,
  • Must own a windows PC (or tablet) or a Mac computer (or laptop),
  • Must have access to Internet service every day.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Physiologic Biorhythms (Skin conductance)

Time Frame: 8 weeks

We will measure the skin conductance at baseline and during the treatment period. We will compare the corresponding patterns in patients with depression, as well as in healthy controls.

Phone Usage

Time Frame: 8 weeks

We will measure the cell-phone usage (in the form of texts, web browsing, and phone calls) at the beginning of the study and during the treatment period. We will compare the corresponding phone usage patterns in patients with depression, as well as in healthy controls.

Voice Characteristics

Time Frame: 8 weeks

We will measure the voice characteristics (via reading a 30-second script as part of an audio diary) at the beginning of the study and during the treatment period. We will compare the corresponding voice characteristics in patients with depression, as well as in healthy controls.

Physiologic Biorhythms (heart rate)

Time Frame: 8 weeks

We will measure the heart rate at baseline and during the treatment period. We will compare the corresponding patterns in patients with depression, as well as in healthy controls.

Study Sites (1)

Loading locations...

Similar Trials